@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix chebi: . @prefix Protein: . @prefix mgi: . @prefix geneProductOf: . @prefix go: . @prefix obo: . @prefix occursIn: . @prefix species: . @prefix do: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 belv:translocationFrom go:0005737; belv:translocationOf sub:_2; belv:translocationTo go:0005634 . sub:_2 geneProductOf: mgi:103290; a Protein: . sub:_3 occursIn: do:1240, obo:CL_0000235, obo:UBERON_0001977, species:10090; rdf:object sub:_1; rdf:predicate belv:increases; rdf:subject chebi:6494; a rdf:Statement . sub:assertion rdfs:label "a(CHEBI:lipopolysaccharide) -> tloc(p(MGI:Rela),GOCCID:0005737,GOCCID:0005634)" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_5; pav:version "20131211" . sub:_4 prov:value "LPS treatment decreased the cytosolic p65 subunit level, resulting in an increase in the nuclear p65 level, while this subunit was located mainly in the cytoplasm of control cells (Figs. 3B and C)."; prov:wasQuotedFrom pubmed:18620044 . sub:_5 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:18620044; prov:wasDerivedFrom beldoc:, sub:_4 . } sub:pubinfo { this: dct:created "2014-07-03T14:33:22.643+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }